Term ends Mar 14, 2034 · High confidence
20-year base term ends Mar 14, 2034
Held by Epizyme, Inc.
Filed Oct 2, 2018 as application 16/149,519 · Granted Apr 28, 2020
Base term, 20 years from filing
Today
2014
2034
Clock starts
Mar 14, 2014
Mar 14, 2014
Term ends
Mar 14, 2034
Mar 14, 2034
Granted
Apr 28, 2020
Apr 28, 2020
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 14, 2014, when application PCT/US2014/028463, the earliest non-provisional in its chain, was filed (this one was filed Oct 2, 2018) | Mar 14, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 14, 2034 | High confidence |
This family
| Application PCT/US2014/028463 | PCT application no patent term | no patent term |
| US 9,738,651 | Lapsed on the fee record Aug 2025 | Aug 2025 |
| US 9,856,267 | Lapsed on the fee record Jan 2026 | Jan 2026 |
| US 10,118,931 | Grace period ended Mar 2034 | Mar 2034 |
| US 10,633,389 | this patent Mar 2034 | Mar 2034 |
| US 11,834,455 | In force no later than Oct 2034 | no later than Oct 2034 |
| Application 18/058,549 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 5, 2019 Reel 48501, frame 413 | Chesworth, Richard; Moradei, Oscar Miguel; Jin, Lei; Shapiro, Gideon; Babine, Robert E. | Epizyme, Inc. | Assignment of Assignor's Interest |
| Nov 19, 2019 Reel 51057, frame 848 | Epizyme, Inc. | Biopharma Credit PLC | Security Interest |
| Aug 13, 2022 Reel 61165, frame 501 | Biopharma Credit PLC | Epizyme, Inc. | Termination and Release of Security Interest in Patents at Reel/Frame: 051057/0848 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2034
Term ends Mar 14, 2034. Maintenance fees still fall due before then
Citations
5
later US patents cite this one
That is above the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.